Cargando…
Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)
BACKGROUND: Renal anemia is an important complication in non-dialysis chronic kidney disease (CKD) patients as well as in dialysis patients. Although recombinant human erythropoietin has dramatically improved prognosis and quality of life in these patients, there have been issues among non-dialysis...
Autores principales: | Kato, Hideki, Nangaku, Masaomi, Hirakata, Hideki, Wada, Takashi, Hayashi, Terumasa, Sato, Hiroshi, Yamazaki, Yasushi, Masaki, Takao, Kagimura, Tatsuo, Yamamoto, Hiroyasu, Hase, Hiroki, Kamouchi, Masahiro, Imai, Enyu, Mizuno, Kyoichi, Iwasaki, Manabu, Akizawa, Tadao, Tsubakihara, Yoshiharu, Maruyama, Shoichi, Narita, Ichiei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805810/ https://www.ncbi.nlm.nih.gov/pubmed/28660446 http://dx.doi.org/10.1007/s10157-017-1427-4 |
Ejemplares similares
-
Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study
por: Narita, Ichiei, et al.
Publicado: (2022) -
Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan
por: Hayashi, Terumasa, et al.
Publicado: (2020) -
Higher hemoglobin levels using darbepoetin alfa and kidney outcomes in advanced chronic kidney disease without diabetes: a prespecified secondary analysis of the PREDICT trial
por: Maruyama, Shoichi, et al.
Publicado: (2023) -
Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan
por: Tanaka, Tetsuhiro, et al.
Publicado: (2018) -
A prospective observational study of early intervention with erythropoietin therapy and renal survival in non-dialysis chronic kidney disease patients with anemia: JET-STREAM Study
por: Akizawa, Tadao, et al.
Publicado: (2016)